Literature DB >> 2817948

Onset and severity of hearing loss due to congenital rubella infection.

N J Wild1, S Sheppard, R W Smithells, H Holzel, G Jones.   

Abstract

Of 111 children born in 1978-82 with congenital rubella infection, confirmed by the detection of rubella specific IgM shortly after birth, 68 were reported to be hearing impaired when notified to the National Congenital Rubella Surveillance Programme (NCRSP). The average age at which the diagnosis of hearing impairment was confirmed was 11.6 months. Recent audiograms showed a hearing loss that was usually uniform across all frequencies, equal in both ears and severe, averaging 93 dB across the range 250-4000 Hz. Despite the early diagnosis of congenital rubella and the known risk of deafness, only eight of 57 infants had been tested for auditory evoked responses in the first 6 months of life; all eight had severe hearing loss. Evidence of progressive hearing loss was found in only one of the 57 children. Definitive hearing tests (as distinct from screening tests) were frequently delayed until after the first birthday. Newborn babies identified as being at high risk of congenital deafness should have a full audiological assessment in early infancy.

Entities:  

Mesh:

Year:  1989        PMID: 2817948      PMCID: PMC1792732          DOI: 10.1136/adc.64.9.1280

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  6 in total

1.  FINAL REPORT OF A PROSPECTIVE STUDY OF CHILDREN WHOSE MOTHERS HAD RUBELLA IN EARLY PREGNANCY.

Authors:  M D SHERIDAN
Journal:  Br Med J       Date:  1964-08-29

2.  Clinical and laboratory study of children exposed in utero to maternal rubella.

Authors:  C S Peckham
Journal:  Arch Dis Child       Date:  1972-08       Impact factor: 3.791

3.  Specific immunoglobulins in infants with the congenital rubella syndrome.

Authors:  J E Cradock-Watson; M K Ridehalgh
Journal:  J Hyg (Lond)       Date:  1976-02

4.  Temporal relations between maternal rubella and congenital defects.

Authors:  N D Munro; S Sheppard; R W Smithells; H Holzel; G Jones
Journal:  Lancet       Date:  1987-07-25       Impact factor: 79.321

5.  Hearing loss and congenital rubella in Atlantic Canada.

Authors:  B Anvar; G T Mencher; S J Keet
Journal:  Ear Hear       Date:  1984 Nov-Dec       Impact factor: 3.570

6.  Age at fitting of hearing aids and speech intelligibility.

Authors:  A Markides
Journal:  Br J Audiol       Date:  1986-05
  6 in total
  5 in total

1.  Delayed detection of congenital hearing loss in high risk infants.

Authors:  N J Wild; S Sheppard; R W Smithells; H Holzel; G Jones
Journal:  BMJ       Date:  1990-10-20

2.  Epidemiology of Congenital Rubella Syndrome (CRS) in India, 2016-18, based on data from sentinel surveillance.

Authors:  Manoj Murhekar; Sanjay Verma; Kuldeep Singh; Ashish Bavdekar; Naveen Benakappa; Sridhar Santhanam; Gajanan Sapkal; Rajlakshmi Viswanathan; Mini P Singh; Vijaya Lakshmi Nag; Sadanand Naik; Munivenkatappa Ashok; Asha Mary Abraham; Devika Shanmugasundaram; R Sabarinathan; Valsan Philip Verghese; Suji George; Ravinder Kaur Sachdeva; Jyoti Kolekar; S Manasa; Jagat Ram; Madhu Gupta; Manoj K Rohit; Praveen Kumar; Parul Chawla Gupta; R K Ratho; Sanjay Kumar Munjal; Urvashi Nehra; Daisy Khera; Neeraj Gupta; Nidhi Kaushal; Pratibha Singh; Ravisekhar Gadepalli; Neelam Vaid; Sandeep Kadam; Sanjay Shah; S Mahantesh; Vykuntaraju K Gowda; Pradeep Haldar; M K Aggarwal; Nivedita Gupta
Journal:  PLoS Negl Trop Dis       Date:  2020-02-03

3.  Profile of congenital rubella syndrome in Soetomo General Hospital Surabaya, Indonesia.

Authors:  Dionisia Vidya Paramita; Nyilo Purnami
Journal:  Infect Dis Rep       Date:  2020-07-06

4.  Congenital Rubella Syndrome profile of audiology outpatient clinic in Surabaya, Indonesia.

Authors:  Elsa Rosalina; Nyilo Purnami
Journal:  Infect Dis Rep       Date:  2020-07-06

Review 5.  Early Life Inflammation and the Developing Hematopoietic and Immune Systems: The Cochlea as a Sensitive Indicator of Disruption.

Authors:  Kelly S Otsuka; Christopher Nielson; Matthew A Firpo; Albert H Park; Anna E Beaudin
Journal:  Cells       Date:  2021-12-20       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.